BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30003030)

  • 1. Identifying preclinical vascular dementia in symptomatic small vessel disease using MRI.
    Lambert C; Zeestraten E; Williams O; Benjamin P; Lawrence AJ; Morris RG; Mackinnon AD; Barrick TR; Markus HS
    Neuroimage Clin; 2018; 19():925-938. PubMed ID: 30003030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia.
    Gyanwali B; Tan CS; Petr J; Escobosa LLT; Vrooman H; Chen C; Mutsaerts HJ; Hilal S
    AJNR Am J Neuroradiol; 2022 Oct; 43(10):1418-1423. PubMed ID: 36562454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal decline in structural networks predicts dementia in cerebral small vessel disease.
    Lawrence AJ; Zeestraten EA; Benjamin P; Lambert CP; Morris RG; Barrick TR; Markus HS
    Neurology; 2018 May; 90(21):e1898-e1910. PubMed ID: 29695593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
    Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Texture Analysis of T1-Weighted and Fluid-Attenuated Inversion Recovery Images Detects Abnormalities That Correlate With Cognitive Decline in Small Vessel Disease.
    Tozer DJ; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Stroke; 2018 Jul; 49(7):1656-1661. PubMed ID: 29866751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.
    Zeestraten EA; Lawrence AJ; Lambert C; Benjamin P; Brookes RL; Mackinnon AD; Morris RG; Barrick TR; Markus HS
    Neurology; 2017 Oct; 89(18):1869-1876. PubMed ID: 28978655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment.
    Banerjee G; Wilson D; Jäger HR; Werring DJ
    Biochim Biophys Acta; 2016 May; 1862(5):926-38. PubMed ID: 26687324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease.
    Hong H; Tozer DJ; Markus HS
    Stroke; 2024 Apr; 55(4):1032-1040. PubMed ID: 38465597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
    Dickie DA; Quinn TJ; Dawson J
    Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
    Dewenter A; Jacob MA; Cai M; Gesierich B; Hager P; Kopczak A; Biel D; Ewers M; Tuladhar AM; de Leeuw FE; Dichgans M; Franzmeier N; Duering M;
    Brain; 2023 Feb; 146(2):678-689. PubMed ID: 35859352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.
    Lawrence AJ; Patel B; Morris RG; MacKinnon AD; Rich PM; Barrick TR; Markus HS
    PLoS One; 2013; 8(4):e61014. PubMed ID: 23613774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.
    Kwan J; Hafdi M; Chiang LLW; Myint PK; Wong LS; Quinn TJ
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012269. PubMed ID: 35833913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
    Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease.
    Lambert C; Benjamin P; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Brain; 2016 Apr; 139(Pt 4):1136-51. PubMed ID: 26936939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
    Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
    BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.